Vimarsana
Biggest News Aggregation in the World

Bio Call News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bio Call. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bio Call Today - Breaking & Trending Today

Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023 - Vimarsana News

Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023

Published: February 23, 2023

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated...

Source: prnewswire.com
Related Topics:
United StatesKristen KelleherKaelan HollonExchange CommissionTrademark OfficeProvention Bio IncPrnewswire Provention Bio IncBio CallProvention BioUnited States PatentSenior Manager
Provention Bio Reports Third Quarter 2022 Financial Results and Provides Business Update - Vimarsana News

Provention Bio Reports Third Quarter 2022 Financial Results and Provides Business Update

Published: November 3, 2022

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today...

Source: prnewswire.com
Related Topics:
Kristen KelleherKaelan HollonOhana BioscienceAshleigh PalmerProvention BioProvention Bio IncDrug AdministrationResearch DevelopmentSobi IncSanofi CoExchange CommissionHangzhou Zhongmei Huadong Pharmaceutical Co LtdPrnewswire Provention Bio IncCorporate CommunicationsHercules Capital IncAdvance PreparationsTeplizumab AheadFee GoalChief Executive OfficerRecent Corporate HighlightsSecurities Purchase AgreementPurchase AgreementSaraho BrienChief PeopleChief People Officer
Provention Bio to Report Third Quarter 2022 Financial Results on November 3, 2022 - Vimarsana News

Provention Bio to Report Third Quarter 2022 Financial Results on November 3, 2022

Published: October 13, 2022

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today...

Source: prnewswire.com
Related Topics:
Kristen KelleherKaelan HollonProvention Bio IncPrnewswire Provention Bio IncDrug AdministrationBio CallProvention BioBiologics License Application
Provention Bio to Combine Forces with Sanofi to Support Potential U.S. Launch of Teplizumab for Delay in Onset of Clinical Type 1 Diabetes (T1D) in At-Risk Individuals - Vimarsana News

Provention Bio to Combine Forces with Sanofi to Support Potential U.S. Launch of Teplizumab for Delay in Onset of Clinical Type 1 Diabetes (T1D) in At-Risk Individuals

Published: October 6, 2022

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated...

Source: prnewswire.com
Related Topics:
United StatesKaelan HollonThierry ChaucheAshleigh PalmerJason HoittOlivier BogillotProvention BioProvention Bio IncExchange Commission OnDrug AdministrationExchange CommissionPrnewswire Provention Bio IncBiologics LicenseChief Commercial OfficerChief Executive OfficerPromotion AgreementFirst NegotiationGlobal CommercialSecurities Purchase AgreementPurchase AgreementCo Promotion AgreementCurrent ReportBio CallBiologics License ApplicationChief Financial
Provention Bio to Report Second Quarter 2022 Financial Results on August 4, 2022 - Vimarsana News

Provention Bio to Report Second Quarter 2022 Financial Results on August 4, 2022

Published: July 28, 2022

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today...

Source: prnewswire.com
Related Topics:
Kaelan HollonRobert DoodyProvention Bio IncPrnewswire Provention Bio IncCorporate CommunicationsDrug AdministrationBio CallProvention BioBiologics License Application